Healthcare Luminaries Alter and Satava Join Patient Innovations Advisory Board

Alter and Satava Healthcare Luminaries
18 May 2019


Patient Innovations is proud to announce that Jeffrey D. Alter, President of Arcturus One Consulting, and Richard M. Satava, MD, FACS, Professor Emeritus of Surgery at the University of Washington Medical Center, have joined its Advisory Board.

Mr. Alter is immediate past Chief Executive Officer of United Healthcare Commercial Group which serves more than 30 million consumers. He serves on the Boards of CityMD, the Long Island Association, the Board of Governors of St John’s University and has other notable Board appointments. Mr. Alter recognized the potential of Patient Innovations’ OnTime Care® platform after meeting Patient Innovations Co-Founders Ken Greenberg and Dr. Akram Boutros. He was responsible for United Healthcare making an initial seed investment in the technology.

Dr. Satava’s prior positions include Professor of Surgery at Yale University, a military appointment as Professor of Surgery at Walter Reed Army Medical Center and was a Program Manager and Senior Science Advisor at DARPA – Defense Advanced Research Projects Agency. His undergraduate training was at Johns Hopkins University and medical training at Hahnemann University of Philadelphia with his internship at Cleveland Clinic and surgical residency at Mayo clinic. During his 23 years of military surgery he has been an active flight surgeon, MASH surgeon for the Grenada invasion and a hospital commander during Desert Storm. He has served on the White House Office of Science and Technology Policy (OSTP) Committee on Health, Food and Safety. He is currently a member of the Emerging Technologies, Resident Education, and Informatics committees of the American College of Surgeons (ACS).

John Tabone, Patient Innovations Chairman & CEO noted, “We’re delighted to welcome Mr. Alter and Dr. Satava to our growing Advisory Board. Their proven leadership experience as well as their business and clinical insights will be invaluable as we scale Patient Innovations. I am excited, and honored, to work with both of these industry leaders.”